» Articles » PMID: 35566707

Body Mass Index and Mortality, Recurrence and Readmission After Myocardial Infarction: Systematic Review and Meta-Analysis

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 May 14
PMID 35566707
Authors
Affiliations
Soon will be listed here.
Abstract

The following study aimed to systematically review and meta-analyse the literature on the relations between markers of nutritional status and long-term mortality, recurrence and all-cause hospital readmission following myocardial infarction (MI). Medline, EMBASE and Web of Science were searched for prospective cohort studies reporting the relationship between anthropometric and biochemical markers of nutritional status and nutritional assessment tools on long-term mortality, recurrence and all-cause hospital readmission in adult patients with an MI. Two reviewers conducted screening, data extraction and critical appraisal independently. Random-effects meta-analysis was performed. Twenty-seven studies were included in the qualitative synthesis and twenty-four in the meta-analysis. All eligible studies analysed BMI as their exposure of interest. Relative to normal weight, mortality was highest in underweight patients (adjusted Hazard Ratio (95% confidence interval): 1.42 (1.24-1.62)) and lower in both overweight (0.85 (0.76-0.94)) and obese patients (0.86 (0.81-0.91)), over a mean follow-up ranging from 6 months to 17 years. No statistically significant associations were identified between different BMI categories for the outcomes of recurrence and hospital readmission. Patients with low BMI carried a significant mortality risk post-MI; however due to the known limitations associated with BMI measurement, further evidence regarding the prognostic utility of other nutritional markers is required.

Citing Articles

Association between BMI and cause-specific long-term mortality in acute myocardial infarction patients.

Schmitz T, Freuer D, Raake P, Linseisen J, Meisinger C Am J Prev Cardiol. 2024; 21:100899.

PMID: 39720766 PMC: 11665372. DOI: 10.1016/j.ajpc.2024.100899.


Unusual infections and thrombotic events in Cushing's syndrome.

Barbot M, Lazzara M, Mazzeo P, Pecori Giraldi F J Endocrinol Invest. 2024; .

PMID: 39352631 DOI: 10.1007/s40618-024-02454-8.


Study on the management effect of chronic disease intelligent information management platform in post percutaneous coronary intervention patients.

Teng X, Sun Y, Zhao L, Kang Y Technol Health Care. 2024; 32(6):4475-4484.

PMID: 39031412 PMC: 11613073. DOI: 10.3233/THC-240621.


Predicting 1 year readmission for heart failure: A comparative study of machine learning and the LACE index.

Song X, Tong Y, Xian F, Luo Y, Tong R ESC Heart Fail. 2024; 11(5):2648-2660.

PMID: 38778700 PMC: 11424322. DOI: 10.1002/ehf2.14855.

References
1.
Bucholz E, Rathore S, Reid K, Jones P, Chan P, Rich M . Body mass index and mortality in acute myocardial infarction patients. Am J Med. 2012; 125(8):796-803. PMC: 3408565. DOI: 10.1016/j.amjmed.2012.01.018. View

2.
Morse S, Gulati R, Reisin E . The obesity paradox and cardiovascular disease. Curr Hypertens Rep. 2010; 12(2):120-6. DOI: 10.1007/s11906-010-0099-1. View

3.
Romero-Corral A, Montori V, Somers V, Korinek J, Thomas R, Allison T . Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006; 368(9536):666-78. DOI: 10.1016/S0140-6736(06)69251-9. View

4.
Rana J, Mukamal K, Morgan J, Muller J, Mittleman M . Obesity and the risk of death after acute myocardial infarction. Am Heart J. 2004; 147(5):841-6. DOI: 10.1016/j.ahj.2003.12.015. View

5.
Fukuoka S, Kurita T, Dohi K, Masuda J, Seko T, Tanigawa T . Untangling the obesity paradox in patients with acute myocardial infarction after primary percutaneous coronary intervention (detail analysis by age). Int J Cardiol. 2019; 289:12-18. DOI: 10.1016/j.ijcard.2019.01.011. View